Document Detail


Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole.
MedLine Citation:
PMID:  18824069     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Locomotor sensitization induced by the dopamine agonist quinpirole can be potentiated by co-treatment with the synthetic kappa opioid agonist U69593. The identification of salvinorin A, an active component of the psychotropic sage Salvia divinorum, as a structurally different agonist of kappa-opioid receptors raised the question of whether this compound would similarly potentiate sensitization to quinpirole. Rats were co-treated with 0.5 mg/kg quinpirole and either salvinorin A (0.04, 0.4 or 2.0 mg/kg) or U69593 (0.3 mg/kg). Control groups were co-treated with vehicle and saline, vehicle and quinpirole (0.5 mg/kg), or saline and salvinorin A (0.4 mg/kg). Rats were injected biweekly for a total of 10 injections and locomotor activity measured after each treatment. Results showed that the highest dose of salvinorin A potentiated sensitization to quinpirole as did U69593, the middle salvinorin A dose had no effect on quinpirole sensitization, and the lowest dose of salvinorin A attenuated sensitization to quinpirole. These findings indicate that structural differences between salvinorin A and U69593 do not affect the potentiation of quinpirole sensitization. Moreover, the opposite effects of high and low salvinorin A doses suggest that salvinorin A can produce bidirectional modulation of sensitization to dopamine agonists.
Authors:
Pieter Beerepoot; Vincent Lam; Alice Luu; Bernice Tsoi; Daniel Siebert; Henry Szechtman
Related Documents :
6085239 - Combined haemodynamic effects of low doses of dopamine and dobutamine in patients with ...
9808259 - 5-ht2a receptor antagonists block mk-801-induced stereotypy and hyperlocomotion.
7514839 - In vivo effects of local and systemic phencyclidine on the extracellular levels of cate...
3588649 - Effects of repeated tiapride administration on anterior pituitary dopamine receptors an...
1208229 - The effects of apomorphine and 1,3-dimethyl-5-aminoadamantane (dmaa) on ponto-geniculo-...
6146709 - Discriminative stimulus properties of lergotrile.
17257899 - Monomeric dr2/mog-35-55 recombinant tcr ligand treats relapses of experimental encephal...
8424569 - Transdermal fentanyl for cancer pain. repeated dose pharmacokinetics.
22757039 - Tu-e-brb-03: biological dose optimization for sbrt of lung cancer: one size does not fi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neuroscience letters     Volume:  446     ISSN:  0304-3940     ISO Abbreviation:  Neurosci. Lett.     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2009-01-28     Completed Date:  2009-02-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7600130     Medline TA:  Neurosci Lett     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  101-4     Citation Subset:  IM    
Affiliation:
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analgesics / pharmacology
Animals
Benzeneacetamides / pharmacology
Central Nervous System / drug effects*,  metabolism
Diterpenes, Clerodane / pharmacology*
Dopamine / metabolism
Dopamine Agents / pharmacology
Dopamine Agonists / pharmacology*
Dose-Response Relationship, Drug
Drug Interactions / physiology
Drug Resistance / drug effects,  physiology
Drug Synergism
Male
Motor Activity / drug effects*,  physiology
Pyrrolidines / pharmacology
Quinpirole / pharmacology*
Rats
Rats, Long-Evans
Receptors, Dopamine D2 / agonists*,  metabolism
Receptors, Dopamine D3 / agonists*
Receptors, Opioid, kappa / agonists,  metabolism
Synaptic Transmission / drug effects,  physiology
Chemical
Reg. No./Substance:
0/Analgesics; 0/Benzeneacetamides; 0/Diterpenes, Clerodane; 0/Dopamine Agents; 0/Dopamine Agonists; 0/Pyrrolidines; 0/Receptors, Dopamine D2; 0/Receptors, Dopamine D3; 0/Receptors, Opioid, kappa; 83729-01-5/salvinorin A; 85760-74-3/Quinpirole; 96744-75-1/U 69593

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analysis of cyanogens with resorcinol and picrate.
Next Document:  Altered neuronal expression of TASK1 and TASK3 potassium channels in rodent and human autoimmune CNS...